XML 16 R5.htm IDEA: XBRL DOCUMENT v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended 6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Jun. 30, 2017
Jun. 30, 2016
Cash Flows from Operating Activities:        
Net loss $ (4) $ (10) $ (10) $ (33)
Adjustments required to reconcile net loss to cash flows from operating activities:        
Depreciation and amortization 130 134 255 282
Deferred tax (benefit) expense (25) 19 (31) 24
Gain on investments (4) (3) (7) (3)
Amortization of debt financing costs 2 0 4 0
Net (gain) loss on sales of businesses and assets (25) 1 (32) 1
Stock-based compensation 12 6 18 10
Restructuring and related costs 34 20 46 45
Payments for restructuring (13) (13) (22) (20)
Contributions to defined benefit pension plans (2) (1) (4) (3)
Provision for receivables (1) 1 (1) 3
Decrease (increase) in accounts receivable 41 28 (69) (113)
Increase in other current and long-term assets (13) (40) (46) (66)
Decrease in accounts payable and accrued compensation (36) (73) (85) (139)
Decrease in other current and long-term liabilities (37) (79) (54) (90)
Net change in income tax assets and liabilities 7 (51) (2) (76)
Other operating, net 1 0 1 0
Net cash provided by (used in) operating activities 67 (61) (39) (178)
Cash Flows from Investing Activities:        
Cost of additions to land, buildings and equipment (20) (25) (37) (55)
Proceeds from sales of land, buildings and equipment 33 0 33 0
Cost of additions to internal use software (7) (11) (15) (20)
Proceeds from sale of businesses, net of adjustments 0 3 0 (53)
Net payments on related party notes receivable 0 3 0 0
Other investing 0 (1) 0 0
Net cash provided by (used in) investing activities 6 (31) (19) (128)
Cash Flows from Financing Activities:        
Proceeds on long term debt, net of issuance costs (8) 2 297 4
Payments on debt (9) (6) (153) (12)
Net payments on related party notes payable 0 (36) 0 (27)
Net transfers from (payments to) former parent 0 151 (161) 362
Proceeds from exercise of stock options 1 0 3 0
Dividends paid on preferred stock (3) 0 (5) 0
Other financing 0 (1) (6) (1)
Net cash (used in) provided by financing activities (19) 110 (25) 326
Effect of exchange rate changes on cash and cash equivalents 0 (1) 2 0
Increase (decrease) in cash and cash equivalents 54 17 (81) 20
Cash and cash equivalents at beginning of period 255 143 390 140
Cash and Cash Equivalents at End of Period $ 309 $ 160 $ 309 $ 160